Microbix Announces Initiation of Normal Course Issuer Bid

by Shitika Kulshreshtha | Dec 5, 2024 | Blog, Media Features News Releases, News Releases

For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, CANADA, December 5, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter,...

KOL Collaborators Present Microbix HPV Test-Control Results

by Shitika Kulshreshtha | Nov 12, 2024 | Blog, Media Features News Releases, News Releases

Validation for use with Self-Collected Samples across Multiple Assays and Media MISSISSAUGA, CANADA, November 12, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that key...

Microbix Presents Novel HSV Test Control at EMMD

by Shitika Kulshreshtha | Oct 7, 2024 | Blog, Media Features News Releases, News Releases

IVDR Compliance and CE Certifications for REDx™ QAPs MISSISSAUGA, CANADA, October 7, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of a novel...

Microbix Achieves Essential EU Regulatory Accreditations

by Shitika Kulshreshtha | Oct 3, 2024 | Blog, Media Features News Releases, News Releases

IVDR Compliance and CE Certifications for REDx™ QAPs MISSISSAUGA, CANADA, October 3, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has upgraded its European Union...

Microbix Presenting at Muskoka Capital Conference

by Shitika Kulshreshtha | Sep 25, 2024 | Blog, Media Features News Releases, News Releases

Meetings with Growth-Oriented Investors, September 27 to 29, 2024 MISSISSAUGA, CANADA, September 25, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting...

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

by Shitika Kulshreshtha | Aug 14, 2024 | Blog, Media Features News Releases, News Releases

Revenues of $5.1 million and Net Income of $0.25 million MISSISSAUGA, CANADA, August 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its third quarter and first...